| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 508 | 7.284 | 15.740 | 16.835 | 6.936 | 18.029 | 3.576 | 25.906 | 33.932 | 27.421 |
| Total Income - EUR | 508 | 7.284 | 15.740 | 16.835 | 7.568 | 18.029 | 3.576 | 25.906 | 33.932 | 27.421 |
| Total Expenses - EUR | 515 | 3.532 | 13.068 | 17.276 | 9.816 | 7.302 | 9.061 | 10.097 | 35.590 | 22.525 |
| Gross Profit/Loss - EUR | -7 | 3.752 | 2.672 | -441 | -2.248 | 10.728 | -5.484 | 15.809 | -1.659 | 4.895 |
| Net Profit/Loss - EUR | -22 | 3.533 | 2.199 | -609 | -2.396 | 10.187 | -5.591 | 15.409 | -1.998 | 4.609 |
| Employees | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Melymed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 3.451 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 714 | 5.545 | 6.623 | 8.722 | 6.608 | 14.450 | 5.582 | 24.504 | 22.788 | 25.961 |
| Inventories | 606 | 754 | 982 | 1.223 | 1.096 | 1.557 | -377 | 960 | 957 | 0 |
| Receivables | 41 | 3.163 | 1.245 | 1.183 | 4 | 8.433 | 4.648 | 13.357 | 8.712 | 22.832 |
| Cash | 67 | 1.628 | 4.396 | 6.317 | 5.508 | 4.460 | 1.312 | 10.187 | 13.118 | 3.129 |
| Shareholders Funds | -2.286 | 1.270 | 3.448 | 2.776 | 325 | 10.506 | 4.681 | 20.105 | 18.046 | 22.554 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.000 | 4.274 | 3.175 | 9.398 | 6.283 | 3.945 | 901 | 4.399 | 4.742 | 3.408 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4941 - 4941" | |||||||||
| CAEN Financial Year |
4779
|
|||||||||
Comments - Melymed Srl